Lower Limb Claudication Due to Bilateral Iliac Artery Occlusive Disease: The Case for Iliac Stenting and Femorofemoral Crossover Bypass

Chapter

References

  1. 1.
    Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381–6.CrossRefPubMedGoogle Scholar
  2. 2.
    McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis. 1991;87:119–28.CrossRefPubMedGoogle Scholar
  3. 3.
    Murabito JM, Evans JC, Nieto K, Larson MG, Levy D, Wilson PW. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J. 2002;143:961–5.CrossRefPubMedGoogle Scholar
  4. 4.
    Howell MA, Colgan MP, Seeger RW, Ramsey DE, Sumner DS. Relationship of severity of lower limb peripheral vascular disease to mortality and morbidity: a six-year follow-up study. J Vasc Surg. 1989;9:691–6.CrossRefPubMedGoogle Scholar
  5. 5.
    Adam DJ, Beard JD, Cleveland T, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366:1925–34.CrossRefPubMedGoogle Scholar
  6. 6.
    Stoyioglou A, Jaff MR. Medical treatment of peripheral arterial disease: a comprehensive review. J Vasc Interv Radiol. 2004;15:1197–207.CrossRefPubMedGoogle Scholar
  7. 7.
    Schanzer A, Mega J, Meadows J, Samson RH, Bandyk DF, Conte MS. Risk stratification in critical limb ischaemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data. J Vasc Surg. 2008;48:1464–71.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Schanzer A, Goodney PP, YouFu L, et al. Validation of the PIII CLI Risk Score for the prediction of amputation-free survival in patients undergoing surgical bypass for critical limb ischaemia. J Vasc Surg. 2009;50:769–75.CrossRefPubMedGoogle Scholar
  9. 9.
    Rose SC. Noninvasive vascular laboratory for evaluation of peripheral arterial occlusive disease. Part II. Clinical applications: chronic atherosclerotic, lower extremity ischaemia. J Vasc Interv Radiol. 2000;11:1257–75.CrossRefPubMedGoogle Scholar
  10. 10.
    Brewster DC. Current controversies in the management of aortoiliac occlusive disease. J Vasc Surg. 1997;25:365–79.CrossRefPubMedGoogle Scholar
  11. 11.
    Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA. Fowkes FGR on behalf of the TASC II working group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33:S54–7.CrossRefGoogle Scholar
  12. 12.
    Pursell R, Sideso E, Magee TR, Galland RB. Critical appraisal of femorofemoral crossover grafts. Br J Surg. 2005;92:565–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Kim YW, Lee JH, Kim HG, Huh S. Factors affecting the long-term patency of crossover femorofemoral bypass graft. Eur J Vasc Endovasc Surg. 2005;30:376–80.CrossRefPubMedGoogle Scholar
  14. 14.
    AbuRahma AF, Robinson PA, Cook CC, Hopkins ES. Selecting patients for combined femorofemoral bypass grafting and iliac balloon angioplasty and stenting for bilateral iliac disease. J Vasc Surg. 2001;33:S93–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Ricco JB, Probst H. French University Surgeons Association. Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease. J Vasc Surg. 2008;47:45–53.CrossRefPubMedGoogle Scholar
  16. 16.
    Porter JM, Eidemiller LR, Dotter CT, Rosch J, Vetto RM. Combined arterial dilatation and femorofemoral bypass for limb salvage. Surg Gynecol Obstet. 1973;137:409–12.PubMedGoogle Scholar
  17. 17.
    Walker PJ, Harris JP, May J. Combined percutaneous transluminal angioplasty and extra-anatomic bypass for symptomatic unilateral iliac occlusion with contralateral iliac artery stenosis. Ann Vasc Surg. 1991;5:209–17.CrossRefPubMedGoogle Scholar
  18. 18.
    Shah RM, Peer RM, Upson JF, Ricotta JJ. Donor iliac angioplasty and crossover femorofemoral bypass. Am J Surg. 1992;164:295–8.CrossRefPubMedGoogle Scholar
  19. 19.
    Perler BA, Williams GM. Does donor iliac artery percutaneous transluminal angioplasty or stent placement influence the results of femorofemoral bypass. Analysis of 70 consecutive cases with long-term follow-up. J Vasc Surg. 1996;24:363–70.CrossRefPubMedGoogle Scholar
  20. 20.
    Schneider JR, Besso SR, Walsh DB, Zwolack RM, Cronenwett JL. Femorofemoral versus aortofemoral bypass. Outcome and hemodynamic results. J Vasc Surg. 1994;19:43–57.CrossRefPubMedGoogle Scholar
  21. 21.
    Criado E, Burnham SJ, Tinsley EA, Johnson G, Keagy BA. Femorofemoral bypass graft: analysis of patency and factors influencing long-term outcome. J Vasc Surg. 1993;18:495–505.CrossRefPubMedGoogle Scholar
  22. 22.
    Brewster DC, Cambria RF, Darling RC, et al. Long-term results of combined iliac balloon angioplasty and distal surgical revascularization. Ann Surg. 1989;210:324–31.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Cynamon J, Marin ML, Veith FJ, et al. Stent-graft repair of aortoiliac occlusive disease coexisting with common femoral artery disease. J Vasc Interv Radiol. 1997;8:19–26.CrossRefPubMedGoogle Scholar
  24. 24.
    Heart Protection Study Collaborative Group. Randomised trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20, 536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg. 2007;45:645–54.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Section of Vascular Surgery and Vascular InterventionUniversity of Poitiers Medical SchoolPoitiersFrance

Personalised recommendations